Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

Basit Öğe Kaydı
dc.contributor.authorOzkan, Metin
dc.contributor.authorBozkurt, Oktay
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorDuzkopru, Yakup
dc.contributor.authorUysal, Mukremin
dc.contributor.authorKaraca, Halit
dc.date.accessioned2024-04-24T17:15:00Z
dc.date.available2024-04-24T17:15:00Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2015.33.15_suppl.e15624
dc.identifier.urihttps://hdl.handle.net/11468/18295
dc.identifier.volume33en_US
dc.identifier.wosWOS:000358036903163
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleIs sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?en_US
dc.titleIs sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu